The return of thalidomide: New uses and renewed concerns

Leprosy Review

Volumn 74, Issue 3, 2003, Pages 286-295

  Pannikar, V ^e   Pereira, G F M ^e   Lockwood, Diana ^a   Bryceson, Anthony ^a   Naafs, Ben ^b,c,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Regional Dermatology Training Centre   (Tanzania)

^d INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; CORTICOSTEROID; PREDNISOLONE; PREDNISONE; THALIDOMIDE;

ABDOMINAL PAIN; ARM MALFORMATION; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONSTIPATION; DIGESTIVE SYSTEM MALFORMATION; DISEASE SEVERITY; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; EAR MALFORMATION; ERYTHEMA NODOSUM LEPROSUM; FOOT MALFORMATION; GENITAL MALFORMATION; HAND MALFORMATION; HUMAN; KIDNEY MALFORMATION; LEG MALFORMATION; LEPROSY; MULTIBACILLARY LEPROSY; NOTE; PERIPHERAL NEUROPATHY; PHOCOMELIA; PIGMENT DISORDER; RASH; RELAPSE; SPINAL CORD MALFORMATION; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; HEALTH POLICY; HUMANS; LEPROSTATIC AGENTS; LEPROSY; TERATOGENS; THALIDOMIDE; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 0141781301     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)